| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.348 | 23.849 | 22.412 | 22.944 | 25.051 | 21.266 | 23.316 | 25.855 | 29.402 | 34.302 |
| Total Income - EUR | 22.698 | 23.850 | 22.639 | 23.969 | 26.839 | 24.867 | 29.309 | 30.108 | 30.891 | 34.306 |
| Total Expenses - EUR | 21.042 | 22.088 | 20.906 | 20.995 | 22.814 | 22.902 | 22.268 | 26.946 | 28.740 | 25.775 |
| Gross Profit/Loss - EUR | 1.656 | 1.762 | 1.733 | 2.975 | 4.025 | 1.966 | 7.041 | 3.162 | 2.151 | 8.530 |
| Net Profit/Loss - EUR | 975 | 1.523 | 1.507 | 2.737 | 3.756 | 1.824 | 6.911 | 2.888 | 1.857 | 7.501 |
| Employees | 5 | 5 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Crisalex Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.787 | 4.667 | 3.545 | 2.536 | 1.669 | 905 | 331 | 0 | 0 | 0 |
| Current Assets | 11.796 | 13.288 | 15.694 | 19.082 | 23.994 | 26.077 | 32.886 | 34.723 | 10.395 | 18.601 |
| Inventories | 8.100 | 485 | 757 | 572 | 607 | 681 | 487 | 619 | 542 | 1.413 |
| Receivables | 209 | 677 | 412 | 823 | 1.072 | 726 | 664 | 499 | 585 | 425 |
| Cash | 3.487 | 12.126 | 14.525 | 17.688 | 22.315 | 24.670 | 31.735 | 33.606 | 9.268 | 16.762 |
| Shareholders Funds | 16.509 | 17.205 | 18.421 | 20.820 | 24.173 | 25.538 | 31.883 | 7.618 | 9.451 | 16.900 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 1.101 | 772 | 861 | 836 | 1.490 | 1.470 | 1.441 | 27.224 | 1.013 | 1.832 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Crisalex Med Srl